±èÁø¹è(Kim Jin-Bae) - °æÈñ´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Abstract
The subcutaneous implantable cardioverter defibrillator (S-ICD) system is intended to provide defibrillation therapy for the treatment of life-threatening ventricular tachyarrhythmias in patients without symptomatic bradycardia, incessant ventricular tachycardia, or spontaneous, frequently recurring ventricular tachycardia that is reliably terminated with anti-tachycardia pacing. Previous clinical studies have shown the clinical efficacy of the S-ICD and that it can be a good alternative to the traditional transvenous implantable cardioverter defibrillator. With technical progress, this novel system will be continuously updated and improved. Therefore, physicians can identify its role and select optimal candidates who will benefit from this new technology.
Å°¿öµå
Sudden Cardiac Death, Implantable Defibrillator
KMID :
1011920150160020101
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
In regard with the efficacy of the S-ICD and that it can be a good alternative to the traditional transvenous implantable cardioverter defibrillator.